Anti-TNF immunogenicity in a Middle Eastern inflammatory bowel disease cohort: prevalence, predictors and context-specific drug level thresholds - Quiz - MDSpire

Anti-TNF immunogenicity in a Middle Eastern inflammatory bowel disease cohort: prevalence, predictors and context-specific drug level thresholds

  • By

  • Shaima Wasim Khan

  • Noorah Al Hosani

  • Thaer Khaleel Swaid

  • Mazin M Edan

  • Mohammed Nabil Quraishi

  • June 26, 2026

  • 0 min

Share

Original Source(s)

Anti-TNF immunogenicity in a Middle Eastern inflammatory bowel disease cohort: prevalence, predictors and context-specific drug level thresholds

  • by Shaima Wasim Khan, Noorah Al Hosani, Thaer Khaleel Swaid, Mazin M Edan, Mohammed Nabil Quraishi

  • June 26, 2026

Related Content

Editorial: Community series in towards precision medicine for immune-mediated disorders: advances in using big data and artificial intelligence to understand heterogeneity in inflammatory responses, volume III

Correction: Incidence of Clostridium difficile infection and enteric pathogens in children with inflammatory bowel disease presenting with disease exacerbation

UCI Health hosts IBD transition of care open house

UCI Health hosted a World IBD Day open house designed to support young adults with inflammatory bowel disease.

  • by

  • June 19, 2026

  • 1 min